Glucose metabolism disorders in cancer patients in a Chinese population

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 177-184

  Zhan, Ya Shi ^a,b   Feng, Lie ^a   Tang, Shao Hui ^a   Li, Wan Geng ^c   Xu, Meng ^a   Liu, Tian Fu ^d   Zhou, You Fen ^a   Ma, Yu Lin ^b   Zhang, Yun ^c   Pu, Xian Ming ^b  

^a JINAN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d Guangzhou Integrated Traditional and Western Hospital   (China)

Author keywords

Cancer; Diabetes mellitus; Glucose metabolism; Hyperglycemia; Hypoglycemia; Impaired fasting glucose

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER PATIENT; CANCER RISK; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; ESOPHAGUS CANCER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; LEUKEMIA; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PANCREAS CANCER; PRIORITY JOURNAL; THYROID CANCER; UTERINE CERVIX CANCER;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; FEMALE; GLUCOSE METABOLISM DISORDERS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 77956929688     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9189-9     Document Type: Article

References (75)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137-50. doi: 10.1200/JCO.2005.05.2308. (Pubitemid 46655601)
2. Magrath I,Litvak J.Cancer in developing countries: opportunity and challenge. J Natl Cancer Inst. 1993;85(11):862-74. doi:10.1093/ jnci/85.11.862.
3. Colonna M, Danzon A, Delafosse P, Mitton N, Bara S, Bouvier AM, et al. Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur J Cancer. 2008;44(1):115-22.doi:10.1016/j.ejca.2007.10.022. (Pubitemid 350256948)
4. World Health Organization. Diabetes mellitus. Geneva, Switzerland: World Health Organization; 2002. p. 138. WHO Fact Sheet.
5. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53. doi:10.2337/diacare.27.5.1047. (Pubitemid 38579764)
6. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54(4):533-9. doi:10.1136/gut. 2004.052167. (Pubitemid 40403031)
7. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med.2006;166(17):1871-7. doi:10.1001/ archinte.166.17.1871. (Pubitemid 44455170)
8. Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49(12): 2819-23. doi:10.1007/s00125-006-0468-0. (Pubitemid 44730282)
9. Washio M, Mori M, Khan M, Sakauchi F, Watanabe Y, Ozasa K, et al. Diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). Int J Urol. 2007;14(5):393-7. doi:10.1111/j.1442-2042.2007.01744.x. (Pubitemid 46776217)
10. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care. 2003; 26(6):1752-8. doi:10.2337/diacare.26.6.1752. (Pubitemid 36929115)
11. Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol. 2008;167(5):607-14. doi:10.1093/aje/kwm333. (Pubitemid 351323306)
12. Kuriki K, Hirose K, Tajima K. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev. 2007;16(1):83-9. doi:10.1097/01.cej.0000228404.37858.40. (Pubitemid 46105011)
13. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(4):921-9. doi:10.1158/ 1055-9965.EPI-07-2686. (Pubitemid 351536424)
14. Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, et al. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology. 2005;129(2):464-75.
15. Bermont L, Lamielle F, Lorchel F, Fauconnet S, Esumi H, Weisz A, et al. Insulin up-regulates vascular endothelial growth factor and stabilizes itsmessengers in endometrial adenocarcinomacells. JClin Endocrinol Metab. 2001;86(1):363-8. doi:10.1210/jc.86.1.363. (Pubitemid 32109819)
16. Yakar S, Pennisi P, Zhao H, Zhang Y, LeRoith D. Circulating IGF-1 and its role in cancer: lessons from the IGF-1 gene deletion (LID) mouse. Novartis Found Symp. 2004;262:3-9; discussion 9-18, 265-8.
17. Renehan AG, Harvie M, Howell A. Insulin-like growth factor (IGF)- I, IGF binding protein-3, and breast cancer risk: eight years on. Endocr Relat Cancer. 2006;13(2):273-8. doi:10.1677/erc.1.01219. (Pubitemid 43886658)
18. Aleksandrovski YA. Molecular mechanisms of the cross-impact of pathological processes in combined diabetes and cancer. Research and clinical aspects. Biochemistry (Mosc). 2002;67(12): 1329-46. doi:10.1023/A:1021801808405.
19. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer- Norfolk study. Cancer Epidemiol Biomarkers Prev. 2004;13(6):915-9.
20. Ely JT, Krone CA. Glucose and cancer. N Z Med J. 2002; 115 (1159):U123.
21. Ramos-Nino ME, MacLean CD, Littenberg B. Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Med. 2007;5:17. doi:10.1186/1741-7015-5-17. (Pubitemid 47226207)
22. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology. 2004;127(4):1044-50. doi:10.1053/j.gastro.2004.07.011. (Pubitemid 39345873)
23. Nan DN, Fernandez-Ayala M, Vega Villegas ME, Garcia-Castano A, Rivera F, Lopez-Brea M, et al. Diabetes mellitus following cisplatin treatment. Acta Oncol. 2003;42(1):75-8. doi:10.1080/0891060310002276. (Pubitemid 36307889)
24. Galassetti P, Tate D, Neill RA, Richardson A, Leu SY, Davis SN. Effect of differing antecedent hypoglycemia on counterregulatory responses to exercise in type 1 diabetes. Am J Physiol Endocrinol Metab. 2006;290(6):E1109-17. doi:10.1152/ajpendo.00244.2005. (Pubitemid 43847893)
25. Venkatraman R, Jayashree M, Singhi S, Marwaha RK. Hyperglycemic hyperosmolar nonketotic syndrome in a child with acute lymphoblastic leukemia undergoing induction chemotherapy: case report. J Pediatr Hematol Oncol. 2005;27(4):234-5. doi:10.1097/01.mph.0000161530.40065.2f. (Pubitemid 40604850)
26. Chala E, Manes C, Iliades H, Skaragkas G, Mouratidou D, Kapantais E. Insulin resistance, growth factors and cytokine levels in overweight women with breast cancer before and after chemotherapy. Hormones (Athens). 2006;5(2):137-46.
27. Tanaka H, Kobayashi A, Bando M, Hosono T, Tsujita A, Yamasawa H, et al. Case of small cell lung cancer complicated with diabetes insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. Nihon Kokyuki Gakkai Zasshi.2007;45(10):793-8.
28. Agha A, Brennan S,Moore KB, Grogan L, Thompson CJ. Small-cell lung cancer presenting as diabetes insipidus and Cushing's syndrome. Pituitary. 2005;8(2):105-7. doi:10.1007/s11102-005-3308-1.
29. Pfeffer F, Koczan D, Adam U, Benz S, von Dobschuetz E, Prall F, et al. Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas. 2004;29(4):284-90. doi:10.1097/00006 676-200411000-00007.
30. Liu H, Xia Y, Cui N. Impact of diabetes mellitus on treatment outcomes in patients with nasopharyngeal cancer. Med Oncol. 2006;23(3):341-6. doi:10.1385/MO:23:3:341. (Pubitemid 44507143)
31. Ujpal M, Barabas J, Szabo G, Bogdan S, Lorincz A, Suba Z. Prognostic significance of type 2 diabetes in patients treated with surgery and irradiation for gingival cancer. Fogorv Sz. 2007;100 (3):99-102.
32. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer. 2007;17(2): 441-6. doi:10.1111/j.1525-1438.2007.00790.x. (Pubitemid 46426761)
33. Chari ST, LeibsonCL,Rabe KG,Timmons LJ,RansomJ, deAndrade M, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134(1):95-101. doi:10.1053/j.gastro.2007.10.040. (Pubitemid 350309328)
34. Geetha N, Lali VS, Hussain BM, Nair MK. Insulin dependent diabetes mellitus induced by chemotherapy and granulocyte, macrophage-colony stimulating factor. J Assoc Physicians India. 1999;47(8):835.
35. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J. 2004;25(22):1990-7. doi:10.1016/j.ehj.2004.09.021. (Pubitemid 39486017)
36. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst. 2006;98(2):135-8. (Pubitemid 43159968)
37. Ehrmann-Josko A, Sieminska J, Gornicka B, Ziarkiewicz-Wroblewska B, Ziolkowski B, Muszynski J. Impaired glucose metabolism in colorectal cancer. Scand J Gastroenterol. 2006;41(9): 1079-86. doi:10.1080/00365520600587444.
38. Calton BA, Chang SC, Wright ME, Kipnis V, Lawson K, Thompson FE, et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control. 2007;18(5):493-503. doi:10.1007/s10552-007-0126-y. (Pubitemid 46684823)
39. Perrin MC, Terry MB, Kleinhaus K, Deutsch L, Yanetz R, Tiram E, et al. Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat. 2008;108(1):129-35. doi:10.1007/s10549-007-9585-9. (Pubitemid 351623245)
40. Hall GC, Roberts CM, Boulis M, Mo J, MacRae KD. Diabetes and the risk of lung cancer. Diabetes Care. 2005;28(3):590-4. doi:10.2337/diacare.28.3.590. (Pubitemid 40315318)
41. Sun G, Vasdev S, Martin GR, Gadag V, Zhang H. Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. Diabetes. 2005;54(11):3336-9. doi:10.2337/diabetes.54.11.3336. (Pubitemid 43334392)
42. Wang F, Gupta S, Holly EA. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1458-63. doi:10.1158/1055-9965.EPI- 06-0188. (Pubitemid 44299315)
43. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat. 2008;109(2):389-95. doi:10.1007/ s10549-007-9654-0.
44. Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC. Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis. 2007;28(7):1561-6. doi:10.1093/carcin/bgm081. (Pubitemid 47241806)
45. Haidar A, Yassin A, Saad F, Shabsigh R. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007;10(4):189-96. doi:10.1080/13685530701653538. (Pubitemid 350146723)
46. Lage MJ, Barber BL, Markus RA. Association between androgen- deprivation therapy and incidence of diabetes among males with prostate cancer. Urology. 2007;70(6):1104-8. doi:10.1016/ j.urology.2007.08.012.
47. Derweesh IH, Diblasio CJ, Kincade MC, Malcolm JB, Lamar KD, Patterson AL, et al. Risk of new-onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer. BJU Int. 2007;100(5):1060-5.
48. Meyer P, Zuern C, Hermanns N, Haak T. The association between paternal prostate cancer and type 2 diabetes. J Carcinog. 2007;6:14. doi:10.1186/1477- 3163-6-14. (Pubitemid 350020760)
49. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2056-62. doi:10.1158/1055-9965.EPI-06-0410. (Pubitemid 44877026)
50. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, et al. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3): 433-40. doi:10.1200/JCO.2003.07.125. (Pubitemid 46606471)
51. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97 (22):1679-87. (Pubitemid 41672234)
52. Assaad SN, Vassilopoulou-Sellin R, Samaan NA. Pseudohypoglycemia in chronic leukemia. Tex Med. 1988;84(7):36-7.
53. Holroyde CP, Skutches CL, Boden G, Reichard GA. Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res. 1984;44(12 Pt 1):5910-3.
54. Lattermann R, Geisser W, Georgieff M, Wachter U, Goertz A, Gnann R, et al. Integrated analysis of glucose, lipid, and urea metabolism in patients with bladder cancer. Impact of tumor stage. Nutrition. 2003;19(7-8):589-92. doi:10.1016/S0899-9007 (03)00055-8.
55. Richards EW, Long CL, Nelson KM, Pinkston JA, Navari RM, Geiger JW, et al. Glucose metabolism in advanced lung cancer patients. Nutrition. 1992;8(4):245-51.
56. Shiba T, Higashi N, Nishimura Y. Hyperglycemia due to insulin resistance caused by interferon-gamma. Diabet Med. 1998;15(5): 435-6. doi:10.1002/(SICI) 1096-9136(199805)15:5<435::AID-DIA 566>3.0.CO;2-N.
57. Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB. Abnormalities in glucose and protein metabolism in noncachectic lung cancer patients. Cancer Res. 1982;42(11):4815-9.
58. Matsuyama T, Tanaka R, Shima K, Nonaka K, Tarui S. Lack of gastrointestinal glucagon response to hypoglycemia in depancreatized dogs. Diabetologia. 1978;15(6):471-4. doi:10.1007/ BF02342872.
59. Diaz R, Aparicio J, Mendizabal A, Faus M, Fleitas T, Aparisi F, et al. Paraneoplastic hyperinsulinism and secondary hypoglycemia in a patient with advanced colon cancer: a rare association. World J Gastroenterol. 2008;14(12):1952-4. doi:10.3748/wjg.14.1952. (Pubitemid 351523832)
60. Bessell EM, Selby C, Ellis IO. Severe hypoglycemia caused by raised insulin-like growth factor II in disseminated breast cancer. J Clin Pathol. 1999;52(10):780-1. doi:10.1136/jcp.52.10.780.
61. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer. 2006;118(8): 2105-9. doi:10.1002/ijc.21600.
62. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159(12):1160-7. doi:10.1093/aje/ kwh161. (Pubitemid 39628057)
63. Batty GD, Shipley MJ, Marmot M, Smith GD. Diabetes status and post-load plasma glucose concentration in relation to sitespecific cancer mortality: findings from the original Whitehall study. Cancer Causes Control. 2004;15(9):873-81. doi:10.1007/s10552-004-1050-z. (Pubitemid 39663863)
64. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005;293(2):194-202. doi:10.1001/jama.293.2.194. (Pubitemid 40095870)
65. Wu Y, Yakar S, Zhao L, Hennighausen L, LeRoith D. Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis. Cancer Res. 2002;62(4):1030-5.
66. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B. Diabetes mellitus and breast cancer. Lancet Oncol. 2005;6(2):103-11. doi: 10.1016/S1470-2045(05) 01736-5. (Pubitemid 40197704)
67. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, et al. Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am J Pathol. 2003;163(3):1001-11.
68. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider. Diabetes Care. 2006;29(8):1990-1. doi:10.2337/dc06-0997. (Pubitemid 44156679)
69. Reinmuth N, Fan F, Liu W. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest. 2002;82(10):1377-89. (Pubitemid 35191541)
70. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50(7):1365-74. doi:10.1007/s00125-007-0681-5. (Pubitemid 46879010)
71. Huxley R. The role of lifestyle risk factors on mortality from colorectal cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev. 2007;8(2):191-8.
72. Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE. Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol. 2007;166(8):932-40. doi:10.1093/aje/kwm170. (Pubitemid 47511687)
73. Huxley R. The impact of modifiable risk factors on mortality from prostate cancer in populations of the Asia-Pacific region. Asian Pac J Cancer Prev. 2007;8(2):199-205.
74. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121(7):1571-8. doi:10.1002/ijc.22788. (Pubitemid 47328718)
75. Kruk J. Association of lifestyle and other risk factors with breast cancer according to menopausal status: A case-control study in the region of WesternPomerania (Poland). Asian Pac J Cancer Prev. 2007;8(4):513-24.